As expected, we found that the majority of LAG-3 was expressed by tumor-infiltrating, but not circulating, CD8 memory T cells, with lower, but detectable, levels of LAG-3 on tumor-infiltrating CD4 T-helper cells and Tregs. Here, LAG3 is linked to neoplasm.